Would you like to receive the latest vacancies in your e-mail box? Create a job alert based on your keyword(s) and preferences.
Share
Technician / Analist R&D
ORCA Therapeutics B.V., a clinical stage biotech company, is looking for an enthusiastic Technician (Analist).
You would join our research and development team in Amsterdam. Be directly involved in the clinical development of our lead compound in prostate cancer patients and work on R&D projects with our scientific team and academic partners.
Job
- Assist in analyses of patient samples
- Performing virus and cell culture experiments
- Maintain, develop, and monitor support processes
- Additional responsibilities, including database management, supply management, and documentation.
- Responsible for correct documentation of GMOs on BSL-2 level.
- Generation of study reports for implementation new virus culture and cell culture procedures describing all experiments performed (under supervision of Manager or supervisor in line)
- Generate SOPs and forms, which describe new virus culture and cell culture procedures performed (under supervision of Manager or supervisor in line)
Profile
Completed education at MBO/HBO level in microbiology, virology and/or immunology.
- Previous experience in Cell culture and Virology
- Familiar with (Q-)PCR and cell sorting technique
- Excellent English language skills, both verbally and written
- Ability to work at biological level II (BSL-2)
- Good communication skills, both verbal and in writing
- Registration skills, both verbal and in writing
- Able to work independently
Benefits
Being based at our R&D labs located in the Amsterdam UMC - VUmc (a short walk from the Amsterdam Zuid train station) you'll have the opportunity to work in a vibrant R&D environment.
- A competitive salary in line with your knowledge and experience
- Re-imbursement of travel cost
- 25 vacation days
- A pension scheme
Company profile
ORCA Therapeutics B.V. is a clinical stage biopharmaceutical company designing and developing new oncolytic immunotherapies for treatment of cancer using Oncolytic Replication Competent Agents (ORCA).
At ORCA, we are passionate about using oncolytic immunotherapies to cure cancer patients. Our proprietary technologies allow us to engineer powerful oncolytics that selectively kill cancer cells and induce an antitumor immune response. ORCA’s lead compound ORCA-010 is currently in clinical development in treatment-naive patients with prostate cancer, with Stage IIa clinical development in esophageal cancer being planned to be started in Q4 2023.
Contact
Please send your CV and any questions to wen.dong@orca-therapeutics.com. For questions regarding this position please contact Wen Dong at +31 648202369.
Please note that Agency Applications Will Not Be Considered.
